Clinical Trial Update: A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions [Phase 1]

View source ↗

Summary

This is a status update for a Phase 1 randomized trial evaluating the TAXUS paclitaxel-eluting stent for de novo coronary artery lesions in coronary heart disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• TAXUS (paclitaxel-eluting stent)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Coronary Heart Disease | Phase 1 | Status: UNKNOWN